Timing your meals could make this hemophilia drug work better
NCT ID NCT07238816
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called Inno8 for hemophilia A. Researchers want to see how eating and drinking before and after taking the pill changes how much medicine gets into the blood. 80 healthy men aged 18-45 will take one dose after fasting, then wait different times before eating again. The results will help doctors give the best dosing instructions for people with hemophilia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Altasciences Clinical LA, Inc.
Cypress, California, 90630, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an ultra-long-acting factor VIII simplify surgery for hemophilia a patients?
- Patient voices take center stage in haemophilia a treatment decisions
- Japanese study tracks Esperoct's Real-World safety over two years
- Japanese hemophilia patients monitored on alhemo in new safety study
- New hope for haemophilia a patients: immune tolerance induction may eliminate clotting factor blockers
- New hope for kids with hemophilia: can SCT800 stop bleeds before they start?